Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

02/02/2021 06:00

Feb 2 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2020        Dec 31, 2019      Mar 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             6.68                8.49              9.40      
                 (-21.3 pct)         (+5.0 pct)        (-13.9 pct)  
  Operating     loss 594 mln        loss 859 mln      loss 600 mln  
  Recurring     loss 460 mln        loss 818 mln      loss 500 mln  
  Net           loss 556 mln          loss 1.56       loss 600 mln  
  EPS          loss 16.03 yen      loss 44.93 yen    loss 17.29 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T